Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma
about
An overview of cutaneous T cell lymphomasCutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents.Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphomaLong-term exposure of MCF-12A normal human breast epithelial cells to ethanol induces epithelial mesenchymal transition and oncogenic features.Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancyEffects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs.STAT5 induces miR-21 expression in cutaneous T cell lymphoma.Microrna-22 controls interferon alpha production and erythroid maturation in response to infectious stress in mice.MicroRNA expression profiling of porcine mammary epithelial cells after challenge with Escherichia coli in vitro.Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer.MicroRNA-22 may promote apoptosis and inhibit the proliferation of hypertrophic scar fibroblasts by regulating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase/p21 pathway.Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas.Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas.MicroRNA-22 Promoted Osteogenic Differentiation of Human Periodontal Ligament Stem Cells by Targeting HDAC6.Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome.The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part III: Polymorphisms of genes involved in Tregs' activation and function.ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer.Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
P2860
Q26740306-EDD435D1-9A44-4FAA-962C-AE7D5DE5269BQ34516083-28C04F13-53CF-4DF7-B64A-C6B589696B5EQ36675064-58B2E98E-4C55-4930-AD04-0CFD5AB44448Q36892620-4B11AB30-8282-4780-80A4-B317BF6187EFQ37702571-C1357869-07AE-4B25-8994-55086FD28CDEQ37835711-B59E3103-E6D7-4308-B9CF-7C99044B5257Q39370677-1A6F74C9-8841-438E-B8E2-99AD53751BAAQ39665695-9631F221-70F3-4CE8-AF91-20C2D45169A6Q40040443-BE1C79D9-0C5A-4FA7-A274-5F5B4E00FE47Q40081343-2164CDBA-AA59-464A-8B27-7CE99BD2B133Q41471256-E70B3D7B-6DA9-4DCD-AEF0-7E3A40F16AA9Q42376417-B0E5A32B-1D49-4AC7-A0A3-8FE51FED8041Q47122404-62EC3E19-C280-40A0-B4A6-6C02E2DAF5C0Q47133172-54C8C6AA-5CBE-41AA-A144-11CEBB3C5B93Q48239992-8FEB1493-6EE5-48D4-8285-5A3B94DF7F93Q48296904-9E20CA36-85D1-4833-BDDD-0100AB71A9C3Q49391905-DD6984E3-476E-45C3-9B63-00279781A73AQ52366358-9DE7D456-9B41-4DBF-8C94-65E6365E9049Q54918383-08DC9EF0-9BCC-41E6-BC96-1D2DC1B47A2B
P2860
Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Jak3, STAT3, and STAT5 inhibit ...... , in cutaneous T-Cell lymphoma
@en
type
label
Jak3, STAT3, and STAT5 inhibit ...... , in cutaneous T-Cell lymphoma
@en
prefLabel
Jak3, STAT3, and STAT5 inhibit ...... , in cutaneous T-Cell lymphoma
@en
P2093
P2860
P50
P356
P1433
P1476
Jak3, STAT3, and STAT5 inhibit ...... , in cutaneous T-Cell lymphoma
@en
P2093
David L Petersen
Denis Sasseville
Ivan V Litvinov
Lars Jønson
Mariusz A Wasik
Niels Odum
Nina A Sibbesen
P2860
P304
20555-20569
P356
10.18632/ONCOTARGET.4111
P407
P50
P577
2015-08-01T00:00:00Z